Improving outcomes for inflammatory bowel disease will depend as much on reforming care delivery as new therapies, with greater transparency, real-time data, and patient-centred models needed to tackle inequities and rising costs.
Amanda Sheppeard is an Associate Editor/Senior Journalist at various esteemed publications. She specializes in medicine and healthcare, covering themes such as digital health, public health, and alternative medicine, with a focus on patient care and telehealth. Amanda's work has been featured in notable outlets including the Cairns Post, The Daily Telegraph, and The Medical Republic.













